Hilton Kira L F, Steyn Hendrik J F, Luthuli Kusasalethu S, Rice Matthew, Streather Bree R, Sweeney Esther, White Lisa J, Morgan Findley R, Rankin Jennifer, Baker Jennifer, Bennett Charlotte, Wilson Hollie B, Hailey Perry A, Garrett Michelle D, Ortega-Roldan Jose L, Sutton J Mark, Hind Charlotte K, Pohl Carolina H, Hiscock Jennifer R
School of Natural Sciences, University of Kent, Canterbury, UK, CT2 7NH.
Department of Microbiology and Biochemistry, Faculty of Natural and Agricultural Sciences, University of the Free State, Free State, South Africa, 9301.
J Mater Chem B. 2025 Jun 16. doi: 10.1039/d5tb00653h.
The rise of antimicrobial resistant (AMR) infection represents a growing threat to the global population and to economic health. The majority of antimicrobial innovations are developed against planktonic microorganisms, however those same microorganisms contained within a biofilm can become over 1000 times more resistant to antimicrobial (including antibiotic) agents. Supramolecular self-associating amphiphiles (SSAs) are a class of amphiphilic salts and related compounds that have shown the potential for development into antibiofilm agents. Within the scope of this work we present five structurally diverse SSAs. We characterise the self-associative properties of these SSAs in the solid state and in solution, before analysing the interactions of these agents with model synthetic membranes and determining their antibiofilm activity against WHO high/critical priority pathogens, and . We also combine SSAs as 1:1 co-formulations and confirm the combination of SSA to inform both SSA phospholipid membrane interaction events and biological activity. Finally, we undertake a series of and DMPK experiments to verify the drug-like properties for these structurally diverse SSAs.
抗菌耐药性(AMR)感染的增加对全球人口和经济健康构成了日益严重的威胁。大多数抗菌创新是针对浮游微生物开发的,然而,生物膜中包含的这些相同微生物对抗菌(包括抗生素)剂的耐药性可能会提高1000倍以上。超分子自缔合两亲物(SSA)是一类两亲盐和相关化合物,已显示出开发成为抗生物膜剂的潜力。在这项工作的范围内,我们展示了五种结构不同的SSA。在分析这些药剂与模型合成膜的相互作用并确定它们对世界卫生组织高/关键优先病原体的抗生物膜活性之前,我们表征了这些SSA在固态和溶液中的自缔合特性。我们还将SSA作为1:1共制剂进行组合,并确认SSA的组合,以了解SSA与磷脂膜的相互作用事件和生物活性。最后,我们进行了一系列药物代谢动力学(DMPK)实验,以验证这些结构不同的SSA的类药物特性。